tafluprost
CHEBI:CHEBI_66899
Definition
A prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Chemical Information
- Molecular Formula
- C25H34F2O5
- Molecular Mass
- 452.53130
- Charge
- 0
- SMILES
- CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COc1ccccc1
- InChI
- InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1
- InChIKey
- WSNODXPBBALQOF-VEJSHDCNSA-N
Alternative Names
- isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate
- tafluprost
- Zioptan
Drug Classification
-
organofluorine compoundView Class →
CHEBI:37143
-
prostaglandins FalphaView Class →
CHEBI:36066
-
isopropyl esterView Class →
CHEBI:35725
-
t269194
-
t269738
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:66899
- oboInOwl#hasDbXref
- Wikipedia:Tafluprost
- DRON_00010000
- 1244607
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_66900
- core#notation
- CHEBI:66899
- rxcui
- 1244611
- pharm_class_epc
- Prostaglandin Analog [EPC]
- pharm_class
- Prostaglandin Receptor Agonists [MoA]
- pharm_class_cs
- Prostaglandins [CS]
- active_ingredient_strength
- .0045 mg/.3mL
- package_marketing_start_date
- 10-FEB-12
- manufacturer_name
- Micro Labs Limited
- active_ingredient_name
- TAFLUPROST
- package_description
- 85 g in 1 BOTTLE (65035-137-85)
- nui
- N0000009526
- spl_set_id
- fcaab8b3-3791-49ba-909e-a09651a30b33
- package_ndc
- 70390-0001-1
- unii
- 1O6WQ6T7G3
- pharm_class_pe
- Increased Prostaglandin Activity [PE]
- pharm_class_moa
- Prostaglandin Receptor Agonists [MoA]
- upc
- 0342571264932
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Tafluprost
- DRON_00010000
- 1244607
- oboInOwl#id
- CHEBI:66899
- brand_name
- Tafluprost
- brand_name_base
- Tafluprost
- product_type
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- OIL
- marketing_start_date
- 20120210
- route
- OPHTHALMIC
- labeler_name
- Zhejiang Ausun Pharmaceutical Co., Ltd.
- generic_name
- tafluprost opthalmic
- product_ndc
- 65035-137
- spl_id
- f0257460-09fc-5264-e053-2995a90af8f7
- application_number
- ANDA209051
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_15553
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect31495
- owl#annotatedSource
- t269843
- owl#someValuesFrom
- t672325